Axcella Health Inc

NASDAQ:AXLA  
2.75
-0.07 (-2.48%)
Other Pre-Announcement

Axcella Reports Fourth Quarter And Full Year 2020 Financial Results And Provides Business Update

Published: 03/17/2021 11:43 GMT
Axcella Health Inc (AXLA) - Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update.
Q4 Loss per Share $0.40.
Q4 Earnings per Share Estimate $-0.36 -- Refinitiv Ibes Data (analyst estimates).
Initiation of Axa1665 Phase 2 Clinical Trial in Ohe Expected in Q2 2021.
Initiation of Axa1125 Phase 2b Clinical Trial in Nash Expected in Q2 2021.